Vir Biotechnology Inc (VIR) stock saw a decline, ending the day at $12.1 which represents a decrease of $-0.38 or -3.04% from the prior close of $12.48. The stock opened at $12.69 and touched a low of ...
In a report released today, Michael Ulz from Morgan Stanley maintained a Buy rating on Mirum Pharmaceuticals (MIRM – Research Report), with a ...
Ulz covers the Healthcare sector, focusing on stocks such as Vir Biotechnology, Alnylam Pharma, and Akero Therapeutics. According to TipRanks, Ulz has an average return of -3.2% and a 35.71% success ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback